Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Norway
/
Healthcare
Create a narrative
Medistim
OB:MEDI Community
Create a narrative
Medistim
Undervalued
Overvalued
Medistim
WA
Analyst Price Target
Consensus Narrative from 1 Analyst
Direct Sales In China, Canada, And Sweden Will Improve Market Control
Key Takeaways Expansion into direct markets in China, Canada, and Sweden aims for higher growth through better control and margins than distributor sales. Focus on Vascular surgery and increased R&D spending promises future growth, operational efficiency, and enhanced customer satisfaction.
View narrative
NOK 172.00
FV
9.0% undervalued
intrinsic discount
3.24%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
MEDI
Medistim
Your Fair Value
NOK
Current Price
NOK 156.50
16.7% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
635m
2015
2018
2021
2024
2025
2027
2030
Revenue NOK 634.6m
Earnings NOK 119.0m
Advanced
Set as Fair Value